Literature DB >> 23322328

Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation.

Forough Saki1, Zohreh Karamizadeh, Shiva Nasirabadi, Steven Mumm, William H McAlister, Michael P Whyte.   

Abstract

Juvenile Paget's disease (JPD) is a rare heritable osteopathy characterized biochemically by markedly increased serum alkaline phosphatase (ALP) activity emanating from generalized acceleration of skeletal turnover. Affected infants and children typically suffer bone pain and fractures and deformities, become deaf, and have macrocranium. Some who survive to young adult life develop blindness from retinopathy engendered by vascular microcalcification. Most cases of JPD are caused by osteoprotegerin (OPG) deficiency due to homozygous loss-of-function mutations within the TNFRSF11B gene that encodes OPG. We report a 3-year-old Iranian girl with JPD and craniosynostosis who had vitamin D deficiency in infancy. She presented with fractures during the first year-of-life followed by bone deformities, delayed development, failure-to-thrive, and pneumonias. At 1 year-of-age, biochemical studies of serum revealed marked hyperphosphatasemia together with low-normal calcium and low inorganic phosphate and 25-hydroxyvitamin D levels. Several family members in previous generations of this consanguineous kindred may also have had JPD and vitamin D deficiency. Mutation analysis showed homozygosity for a unique missense change (c.130T>C, p.Cys44Arg) in TNFRSF11B that would compromise the cysteine-rich domain of OPG that binds receptor activator of NF-κB ligand (RANKL). Both parents were heterozygous for this mutation. The patient's serum OPG level was extremely low and RANKL level markedly elevated. She responded well to rapid oral vitamin D repletion followed by pamidronate treatment given intravenously. Our patient is the first Iranian reported with JPD. Her novel mutation in TNFRSF11B plus vitamin D deficiency in infancy was associated with severe JPD uniquely complicated by craniosynostosis. Pamidronate treatment with vitamin D sufficiency can be effective therapy for the skeletal disease caused by the OPG deficiency form of JPD.
Copyright © 2013 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23322328      PMCID: PMC3663917          DOI: 10.1002/jbmr.1868

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  23 in total

1.  CRANIOSYNOSTOSIS IN THE RACHITIC SPECTRUM.

Authors:  B J REILLY; J M LEEMING; D FRASER
Journal:  J Pediatr       Date:  1964-03       Impact factor: 4.406

2.  Osteitis deformans (Paget's disease) in an 11 year old boy.

Authors:  C CHOREMIS; D YANNAKOS; C PAPADATOS; E BAROUTSOU
Journal:  Helv Paediatr Acta       Date:  1958-04

3.  Fragile bones and macrocranium.

Authors:  H BAKWIN; M S EIGER
Journal:  J Pediatr       Date:  1956-11       Impact factor: 4.406

4.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  Chronic idiopathic hyperphosphatasia associated with pseudoxanthoma elasticum.

Authors:  S M Mitsudo
Journal:  J Bone Joint Surg Am       Date:  1971-03       Impact factor: 5.284

6.  Characterization of structural domains of human osteoclastogenesis inhibitory factor.

Authors:  K Yamaguchi; M Kinosaki; M Goto; F Kobayashi; E Tsuda; T Morinaga; K Higashio
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

7.  Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor.

Authors:  T Morinaga; N Nakagawa; H Yasuda; E Tsuda; K Higashio
Journal:  Eur J Biochem       Date:  1998-06-15

8.  Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapy.

Authors:  Cristina Tau; Carlos Mautalen; Cristina Casco; Verónica Alvarez; Marta Rubinstein
Journal:  Bone       Date:  2004-07       Impact factor: 4.398

9.  Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.

Authors:  D W Banner; A D'Arcy; W Janes; R Gentz; H J Schoenfeld; C Broger; H Loetscher; W Lesslauer
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

10.  Visual impairment in a case of juvenile Paget's disease with pseudoxanthoma elasticum: an eleven year follow up.

Authors:  K W Sharif; W M Doig; F P Kinsella
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1989 Nov-Dec       Impact factor: 1.402

View more
  11 in total

1.  Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.

Authors:  Michael P Whyte; Cristina Tau; William H McAlister; Xiafang Zhang; Deborah V Novack; Virginia Preliasco; Eduardo Santini-Araujo; Steven Mumm
Journal:  Bone       Date:  2014-07-23       Impact factor: 4.398

Review 2.  Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain.

Authors:  Toshiyuki Yoneda; Masahiro Hiasa; Yuki Nagata; Tatsuo Okui; Fletcher White
Journal:  Biochim Biophys Acta       Date:  2015-02-14

3.  Acquired resistance to pamidronate treated effectively with zoledronate in juvenile Paget's disease.

Authors:  E N Gonc; A Ozon; G Buyukyilmaz; A Alikasifoglu; O P Simsek; N Kandemir
Journal:  Osteoporos Int       Date:  2018-03-03       Impact factor: 4.507

Review 4.  Rare Inherited forms of Paget's Disease and Related Syndromes.

Authors:  Stuart H Ralston; J Paul Taylor
Journal:  Calcif Tissue Int       Date:  2019-02-13       Impact factor: 4.333

Review 5.  Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids.

Authors:  Joana Krämer; Rui Kang; Laura M Grimm; Luisa De Cola; Pierre Picchetti; Frank Biedermann
Journal:  Chem Rev       Date:  2022-01-07       Impact factor: 60.622

Review 6.  Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease.

Authors:  Gary S Gottesman; Katherine L Madson; William H McAlister; Angela Nenninger; Deborah Wenkert; Steven Mumm; Michael P Whyte
Journal:  Am J Med Genet A       Date:  2016-01-14       Impact factor: 2.802

7.  CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts.

Authors:  Matthew B Greenblatt; Kwang Hwan Park; Hwanhee Oh; Jung-Min Kim; Dong Yeon Shin; Jae Myun Lee; Jin Woo Lee; Anju Singh; Ki-young Lee; Dorothy Hu; Changchun Xiao; Julia F Charles; Josef M Penninger; Sutada Lotinun; Roland Baron; Sankar Ghosh; Jae-Hyuck Shim
Journal:  J Exp Med       Date:  2015-07-20       Impact factor: 14.307

8.  Polymorphisms of CSF1 and TM7SF4 genes in a case of mild juvenile Paget's disease found using next-generation sequencing.

Authors:  Judit Donáth; Gábor Speer; János P Kósa; Kristóf Árvai; Bernadett Balla; Péter Juhász; Péter Lakatos; Gyula Poór
Journal:  Croat Med J       Date:  2015-04       Impact factor: 1.351

9.  Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7).

Authors:  Michael P Whyte; Philippe M Campeau; William H McAlister; G David Roodman; Nori Kurihara; Angela Nenninger; Shenghui Duan; Gary S Gottesman; Vinieth N Bijanki; Homer Sedighi; Deborah J Veis; Steven Mumm
Journal:  Bone       Date:  2020-04-13       Impact factor: 4.398

10.  Mutations in Profilin 1 Cause Early-Onset Paget's Disease of Bone With Giant Cell Tumors.

Authors:  Zhe Wei; Shanshan Li; Xiaohui Tao; Guoying Zhu; Zhenkui Sun; Zhanying Wei; Qiong Jiao; Huizhen Zhang; Lin Chen; Baojie Li; Zhenlin Zhang; Hua Yue
Journal:  J Bone Miner Res       Date:  2021-03-10       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.